Search Results 1-10 of 15897 for Emicizumab
Description. Emicizumab-kxwh injection is used to prevent or decrease the frequency of bleeding episodes in patients with hemophilia A (congenital Factor VIII ...
About this study. The purpose of this study is to evaluate the effectiveness of prophylactic emicizumab administered on a scheduled basis to prevent bleeds ...
Emicizumab (Hemlibra). This is a newer drug that doesn't include clotting factors. This drug can help prevent bleeding episodes in people with hemophilia A ...
Emicizumab; Fitusiran; Tranexamic Acid. Other Interactions. Certain medicines should not be used at or around the time of eating food or eating certain types of ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to analyze the effect of sacituzumab govitecan in treating patients with HER2-negative breast cancer that has spread to the brain ( ...
Enzyme inhibitors, such as ibrutinib and ixazomib citrate, may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
Mepolizumab injection is used with other medicines to treat severe asthma. It is given to patients whose asthma is not controlled with their current asthma ...
About this study. Mepolizumab is a humanized monoclonal antibody. In conditions where eosinophilia is considered to play an important part in the pathology, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.